Skip to content

Advertisement

  • Poster presentation
  • Open Access

Dexamethasone treatment during cardiac surgery and postoperative lactate levels

  • 1,
  • 1,
  • 1,
  • 1 and
  • 1
Critical Care201014 (Suppl 1) :P585

https://doi.org/10.1186/cc8817

  • Published:

Keywords

  • Hydrocortisone
  • Dexamethasone
  • Glucocorticoid
  • Cardiopulmonary Bypass
  • Mitochondrial Membrane Potential

Introduction

Glucocorticoids are known to have an anti-insulin action on glucose metabolism, leading to increased lactate production [1]. Alternatively, glucocorticoid-induced apoptosis is a well-recognized phenomenon initiated by mitochondrial dysfunction [2]. Increased lactate production follows loss of mitochondrial membrane potential during apoptosis. Both mechanisms may lead to clinically relevant hyperlactatemia following glucocorticoid administration during cardiac surgery requiring cardiopulmonary bypass.

Methods

All adult patients undergoing cardiac surgery and cardiopulmonary bypass from 5 October through 21 November 2005 in a large academic teaching hospital in Rotterdam, the Netherlands were included in this study. Dexamethasone (60 to 80 mg) was given perioperatively at the discretion of the anesthetist. Lactate levels were measured within 1 hour postoperatively. The association between dexamethasone treatment, serum lactate levels and possible confounders was evaluated using ANOVA and linear regression.

Results

A total of 82 patients 18 years and older underwent cardiopulmonary bypass for cardiac surgery in the above-mentioned period. Three patients undergoing heart or lung transplantation, who thus received methylprednisolone, were excluded; a further two patients who received hydrocortisone for allergic reactions were also excluded. Data were incomplete for one patient, leaving a total of 76 patients for analysis. The mean lactate level was 1.2 mmol/l in the 47 patients who did not receive steroids and 2.6 mmol/l in the 29 patients who received dexamethasone (P < 0.0001, Figure 1). When adjusting for potential confounders such as age, glucose level, duration of cardiopulmonary bypass and preoperative NYHA heart failure classification, this difference remained significant (P < 0.0001).
Figure 1
Figure 1

Serum lactate levels in patients with and without dexamethasone during cardiopulmonary bypass.

Conclusions

Administration of dexamethasone during cardiac surgery requiring cardiopulmonary bypass is associated with a significant hyperlactatemia.

Authors’ Affiliations

(1)
Erasmus MC, Rotterdam, the Netherlands

References

  1. Plager JE, et al.: Endocrinology. 1966, 78: 1154-1158. 10.1210/endo-78-6-1154PubMedView ArticleGoogle Scholar
  2. Distelhorst CW, et al.: Cell Death Diff. 2002, 9: 6-19. 10.1038/sj.cdd.4400969View ArticleGoogle Scholar

Copyright

© BioMed Central Ltd. 2010

Advertisement